In the meantime, overexpression of DIRAS3 promotes glioma cell proliferation and invasion via EGFR‐AKT signalling pathway.31 Our study was identical to the opinion that DIRAS3 was correlated with poor prognosis of GBM and was a risk factor for GBM survival. The gene discussed is EGFR; the disease is glioblastoma.